In response to the COVID-19 pandemic, Clinical Trials BC is leading additional projects:

COVID-19 capacity added to the Clinical Trials Asset Map

We are updating the BC Research Capacity in the Canadian Clinical Trials Asset Map (CCTAM) and we need your help!

The asset map allows for effective collaboration among research sites and demonstrated capacity for clinical trials – in particular, COVID-19 capacity at this current time. Additionally, it serves as a tool enabling clinical trial sponsors to locate investigators, clinical research sites, hospitals, institutions, research ethics for the conduct of trials as well as enabling investigators to engage in investigator-initiated research.

What do we need from you?

  • If you are a clinical research organization, site, agency, hospital, institution, investigator, ethics board, or university, and you are not in our asset map, please create your profile here.
  • If you are already in our asset map, please login and review your profile to make sure it is up to date and demonstrate if you are able to support COVID-19 research.

Trial Linking Services

Clinical Trials BC links sponsors, investigators and sites with one another. Any COVID-19 studies are a current priority. Please contact Alison Orth if you require linking or navigation. We are setting up a COVID-19 specific Clinical Trial Listing for the province. For more information about clinical trial capacity in BC please visit our BC Showcase website which includes a directory of clinical trial investigators, sites and research institutions.

 

If you have any questions about these initiatives or require support, please contact Sarah Hanif.